Whelan J - Search Results

1

Current approaches to management of bone sarcoma in adolescent and young adult patients.

Ingley KM, Maleddu A, Grange FL, Gerrand C, Bleyer A, Yasmin E, Whelan J, Strauss SJ. Ingley KM, et al. Among authors: whelan j. Pediatr Blood Cancer. 2022 Feb;69(2):e29442. doi: 10.1002/pbc.29442. Epub 2021 Nov 12. Pediatr Blood Cancer. 2022. PMID: 34767314 Review.

2

Single center experience of a new intensive induction therapy for ewing's family of tumors: feasibility, toxicity, and stem cell mobilization properties.

Strauss SJ, McTiernan A, Driver D, Hall-Craggs M, Sandison A, Cassoni AM, Kilby A, Michelagnoli M, Pringle J, Cobb J, Briggs T, Cannon S, Witt J, Whelan JS. Strauss SJ, et al. Among authors: whelan js. J Clin Oncol. 2003 Aug 1;21(15):2974-81. doi: 10.1200/JCO.2003.04.106. J Clin Oncol. 2003. PMID: 12885818

3

Carboplatin-based chemotherapy for refractory and recurrent Ewing's tumours.

Whelan JS, McTiernan A, Kakouri E, Kilby A; London Bone and Soft Tissue Tumour Service. Whelan JS, et al. Pediatr Blood Cancer. 2004 Sep;43(3):237-42. doi: 10.1002/pbc.20107. Pediatr Blood Cancer. 2004. PMID: 15266407

4

Late relapse of osteosarcoma: implications for follow-up and screening.

Strauss SJ, McTiernan A, Whelan JS. Strauss SJ, et al. Among authors: whelan js. Pediatr Blood Cancer. 2004 Nov;43(6):692-7. doi: 10.1002/pbc.20154. Pediatr Blood Cancer. 2004. PMID: 15390283

5

A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma.

McTiernan A, Meyer T, Michelagnoli MP, Lewis I, Whelan JS. McTiernan A, et al. Pediatr Blood Cancer. 2006 Mar;46(3):345-50. doi: 10.1002/pbc.20562. Pediatr Blood Cancer. 2006. PMID: 16206197 Clinical Trial.

6

High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours.

McTiernan A, Driver D, Michelagnoli MP, Kilby AM, Whelan JS. McTiernan A, et al. Among authors: whelan js. Ann Oncol. 2006 Aug;17(8):1301-5. doi: 10.1093/annonc/mdl108. Epub 2006 Jun 16. Ann Oncol. 2006. PMID: 16782749 Free article.

7

Experimental therapies in Ewing's sarcoma.

Windsor R, Strauss S, Seddon B, Whelan J. Windsor R, et al. Among authors: whelan j. Expert Opin Investig Drugs. 2009 Feb;18(2):143-59. doi: 10.1517/13543780802715784. Expert Opin Investig Drugs. 2009. PMID: 19236262 Review.

8

The role of interferons in the treatment of osteosarcoma.

Whelan J, Patterson D, Perisoglou M, Bielack S, Marina N, Smeland S, Bernstein M. Whelan J, et al. Pediatr Blood Cancer. 2010 Mar;54(3):350-4. doi: 10.1002/pbc.22136. Pediatr Blood Cancer. 2010. PMID: 19902521 Review.

9

Understanding micrometastatic disease and Anoikis resistance in ewing family of tumors and osteosarcoma.

Strauss SJ, Ng T, Mendoza-Naranjo A, Whelan J, Sorensen PH. Strauss SJ, et al. Among authors: whelan j. Oncologist. 2010;15(6):627-35. doi: 10.1634/theoncologist.2010-0093. Epub 2010 May 17. Oncologist. 2010. PMID: 20479280 Free PMC article. Review.

10

UK Guidelines for the Management of Bone Sarcomas.

Grimer R, Athanasou N, Gerrand C, Judson I, Lewis I, Morland B, Peake D, Seddon B, Whelan J. Grimer R, et al. Among authors: whelan j. Sarcoma. 2010;2010:317462. doi: 10.1155/2010/317462. Epub 2010 Dec 29. Sarcoma. 2010. PMID: 21253474 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,140 results

Search Page